Skip to main content

View full-text article in PMC

. 2017 Sep 27;40(6):1657–1668. doi: 10.3892/ijmm.2017.3153

Table I.

Composition of the subtypes of oligodendrocytes in the presence of different concentrations of CSPGs and LN.

CSPGs (µg/ml)	LN (µg/ml)	Subtype of oligodendrocyte
CSPGs (µg/ml)	LN (µg/ml)	I	II	III	IV
0	10	1.00±1.00	3.67±1.15	11.00±4.58	84.33±4.04
	5	5.33±1.15^a	7.67±1.15	17.67±2.52^b	69.33±3.79^b
	1	9.00±2.00^b	16.7±2.08^b	37.00±1.00^b	37.33±3.06^b
2.5	10	9.67±2.52^b	15.33±1.53^b	35.00±4.00^b	40.00±4.36^b
	5	8.67±2.52^b	34.00±5.29^b	26.67±2.08^b	30.67±4.04^b
	1	8.33±1.52^b	51.67±2.08^b	25.00±3.00^b	15.00±1.00^b
5	10	8.33±1.52^b	47.00±4.00^b	28.67±2.31^b	16.00±3.60^b
	5	20.33±2.52^b	53.00±2.64^b	20.33±2.08^b	6.33±1.53^b
	1	41.33±3.60^b	53.66±4.72^b	4.33±1.53^b	1.00±1.00^b

^a

P<0.05 and

^b

P<0.01 vs. the control group (0 µg/ml CSPGs and 10 µg/ml laminin). LN, laminin; CSPGs, chondroitin sulfate proteoglycan.